Cryptococcal meningitisBICANIC, Tihana; HARRISON, Thomas S.British medical bulletin. 2004, Vol 72, pp 99-118, issn 0007-1420, 20 p.Article

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised PatientsO'CONNOR, Lucy; LIVERMORE, Joanne; PERFECT, John R et al.The Journal of infectious diseases. 2013, Vol 208, Num 2, pp 351-361, issn 0022-1899, 11 p.Article

Pharmacokinetics and Pharmacodynamics of Fluconazole for Cryptococcal Meningoencephalitis: Implications for Antifungal Therapy and In Vitro Susceptibility BreakpointsSUDAN, Ajay; LIVERMORE, Joanne; HARRISON, Thomas S et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2793-2800, issn 0066-4804, 8 p.Article

Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitisBROUWER, Annemarie E; TEPARRUKKUL, Paprit; PINPRAPHAPORN, Supraphada et al.The Journal of infectious diseases. 2005, Vol 192, Num 4, pp 681-684, issn 0022-1899, 4 p.Article

Immunotherapy for fungal infectionsARMSTRONG-JAMES, Darius; HARRISON, Thomas S.Current opinion in microbiology. 2012, Vol 15, Num 4, pp 434-439, issn 1369-5274, 6 p.Article

Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South AfricaJARVIS, Joseph N; MEINTJES, Graeme; HARRISON, Thomas S et al.The Journal of infection. 2010, Vol 60, Num 6, pp 496-498, issn 0163-4453, 3 p.Article

HIV-associated cryptococcal meningitisJARVIS, Joseph N; HARRISON, Thomas S.AIDS (London). 2007, Vol 21, Num 16, pp 2119-2129, issn 0269-9370, 11 p.Article

Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal MeningitisJARVIS, Joseph N; BICANIC, Tihana; LOYSE, Angela et al.Clinical infectious diseases. 2014, Vol 59, Num 4, pp 493-500, issn 1058-4838, 8 p.Article

Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal MeningitisLOYSE, Angela; WILSON, Douglas; WOOD, Robin et al.Clinical infectious diseases. 2012, Vol 54, Num 1, pp 121-128, issn 1058-4838, 8 p.Article

Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in MalawiNUSSBAUM, Jesse C; JACKSON, Arthur; VAN DER HORST, Charles M et al.Clinical infectious diseases. 2010, Vol 50, Num 3, pp 338-344, issn 1058-4838, 7 p.Article

Should Antiretroviral Therapy Be Delayed for 10 Weeks for Patients Treated with Fluconazole for Cryptococcal Meningitis?BICANIC, Tihana; JARVIS, Joseph N; MUZOORA, Conrad et al.Clinical infectious diseases. 2010, Vol 51, Num 8, pp 986-987, issn 1058-4838, 2 p.Article

Dose Response Effect of High-Dose Fluconazole for HIV-Assodated Cryptococcal Meningitis in Southwestern UgandaLONGLEY, Nicky; MUZOORA, Conrad; TASEERA, Kabanda et al.Clinical infectious diseases. 2008, Vol 47, Num 12, pp 1556-1561, issn 1058-4838, 6 p.Article

The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohortPATEL, Sheel; GEE YEN SHIN; WIJEWARDANA, Ishan et al.The Journal of infection. 2013, Vol 66, Num 1, pp 75-79, issn 0163-4453, 5 p.Article

Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal MeningitisJARVIS, Joseph N; PERCIVAL, Ann; BAUMAN, Sean et al.Clinical infectious diseases. 2011, Vol 53, Num 10, pp 1019-1023, issn 1058-4838, 5 p.Article

Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: The role of inadequate secondary prophylaxisJARVIS, Joseph N; MEINTJES, Graeme; WILLIAMS, Zomzi et al.SAMJ. South African medical journal. 2010, Vol 100, Num 6, pp 378-382, issn 0256-9574, 5 p.Article

Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised PatientsLAMBOURNE, Jonathan; AGRANOFF, Dan; WHITE, P. Lewis et al.Clinical infectious diseases. 2009, Vol 49, Num 10, pp 1486-1491, issn 1058-4838, 6 p.Article

Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitisBROUWER, Annemarie E; VAN KAN, Hendrikus J. M; JOHNSON, Elizabeth et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 3, pp 1038-1042, issn 0066-4804, 5 p.Article

Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformansLARSEN, Robert A; BAUER, Madeline; THOMAS, Ann M et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3297-3301, issn 0066-4804, 5 p.Article

Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal MeningitisROBERTSON, Emma J; NAJJUKA, Grace; HARRISON, Thomas S et al.The Journal of infectious diseases. 2014, Vol 209, Num 1, pp 74-82, issn 0022-1899, 9 p.Article

A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitisJACKSON, Arthur T; NUSSBAUM, Jesse C; HARRISON, Thomas S et al.AIDS (London). 2012, Vol 26, Num 11, pp 1363-1370, issn 0269-9370, 8 p.Article

Large volume lumbar punctures in cryptococcal meningitis clear cryptococcal antigen as well as lowering pressureWIJEWARDANA, Ishan; JARVIS, Joseph N; MEINTJES, Graeme et al.The Journal of infection. 2011, Vol 63, Num 6, pp 484-486, issn 0163-4453, 3 p.Article

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaPERFECT, John R; DISMUKES, William E; PAPPAS, Peter G et al.Clinical infectious diseases. 2010, Vol 50, Num 3, pp 291-322, issn 1058-4838, 32 p.Article

Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?JARVIS, Joseph N; HARRISON, Thomas S; CORBETT, Elizabeth L et al.AIDS (London). 2010, Vol 24, Num 4, pp 612-614, issn 0269-9370, 3 p.Article

High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll outJARVISA, Joseph N; BOULLE, Andrew; LOYSE, Angela et al.AIDS (London). 2009, Vol 23, Num 9, pp 1182-1183, issn 0269-9370, 2 p.Article

Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophagesCOX, Gary M; HARRISON, Thomas S; MCDADE, Henry C et al.Infection and immunity. 2003, Vol 71, Num 1, pp 173-180, issn 0019-9567, 8 p.Article